Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1118

1.

Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.

Huang PH, Kuo CJ, Lin CW, Cheng YM, Hu HC, Lin CY, Su MY, Chiu CT.

Medicine (Baltimore). 2018 Nov;97(48):e13242. doi: 10.1097/MD.0000000000013242.

2.

Facile surface functionalization of upconversion nanoparticles with phosphoryl pillar[5]arenes for controlled cargo release and cell imaging.

Wang X, Yang J, Sun X, Yu H, Yan F, Meguellati K, Cheng Z, Zhang H, Yang YW.

Chem Commun (Camb). 2018 Nov 15;54(92):12990-12993. doi: 10.1039/c8cc08168a.

PMID:
30387478
3.

Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.

Iannone A, Ruospo M, Wong G, Barone M, Principi M, Di Leo A, Strippoli GFM.

Can J Gastroenterol Hepatol. 2018 Sep 16;2018:5437135. doi: 10.1155/2018/5437135. eCollection 2018.

4.
5.

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.

Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group.

Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7.

6.

Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?

Huguet JM, Iborra M, Bosca-Watts MM, Maroto N, Gil R, Cortes X, Hervás D, Paredes JM.

Scand J Gastroenterol. 2018 Sep;53(9):1079-1084. doi: 10.1080/00365521.2018.1501603. Epub 2018 Sep 6.

PMID:
30189153
7.

The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.

Yamauchi R, Araki T, Mitsuyama K, Tokito T, Ishii H, Yoshioka S, Kuwaki K, Mori A, Yoshimura T, Tsuruta O, Torimura T.

BMC Gastroenterol. 2018 Aug 31;18(1):135. doi: 10.1186/s12876-018-0864-1. Review.

8.

The safety of beclomethasone dipropionate in the treatment of ulcerative colitis.

Rizzello F, Mazza M, Salice M, Calabrese C, Calafiore A, Campieri M, Gionchetti P.

Expert Opin Drug Saf. 2018 Sep;17(9):963-969. doi: 10.1080/14740338.2018.1510914. Epub 2018 Aug 21. Review.

PMID:
30101623
9.

Enteral nutrition for maintenance of remission in Crohn's disease.

Akobeng AK, Zhang D, Gordon M, MacDonald JK.

Cochrane Database Syst Rev. 2018 Aug 11;8:CD005984. doi: 10.1002/14651858.CD005984.pub3.

PMID:
30098021
10.

Comparison table: some drugs for inflammatory bowel disease.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):e117-e122. No abstract available.

PMID:
30036356
11.

Drugs for inflammatory bowel disease.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):107-114. No abstract available.

PMID:
30036352
12.

A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity Reactions.

Hirono H, Watanabe K, Hasegawa K, Honma T, Ajioka Y, Ohkoshi S.

Am J Case Rep. 2018 May 31;19:623-629. doi: 10.12659/AJCR.909644.

13.

Diversion colitis and pouchitis: A mini-review.

Tominaga K, Kamimura K, Takahashi K, Yokoyama J, Yamagiwa S, Terai S.

World J Gastroenterol. 2018 Apr 28;24(16):1734-1747. doi: 10.3748/wjg.v24.i16.1734. Review.

14.

Antioxidant and anti-inflammatory effect of plumieride in dextran sulfate sodium-induced colitis in mice.

Boeing T, de Souza P, Bonomini TJ, Mariano LNB, Somensi LB, Lucinda RM, Malheiros A, da Silva LM, Andrade SF.

Biomed Pharmacother. 2018 Mar;99:697-703. doi: 10.1016/j.biopha.2018.01.142. Epub 2018 Feb 20.

PMID:
29710467
15.

Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis.

Chen YL, Zhang YL, Dai YC, Tang ZP.

World J Gastroenterol. 2018 Apr 7;24(13):1398-1409. doi: 10.3748/wjg.v24.i13.1398.

16.

Concurrent Sweet's syndrome and myopericarditis following mesalamine therapy.

Shabtaie SA, Tan NY, Parikh RS, Papadakis KA.

BMJ Case Rep. 2018 Mar 23;2018. pii: bcr-2017-223851. doi: 10.1136/bcr-2017-223851.

PMID:
29574433
17.

Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting: A case report.

Lin Z, Zhu B, Jin X.

Medicine (Baltimore). 2018 Mar;97(11):e0104. doi: 10.1097/MD.0000000000010104.

18.

A safety evaluation of budesonide MMX for the treatment of ulcerative colitis.

Bezzio C, Festa S, Zerboni G, Papi C, Manes G, Saibeni S.

Expert Opin Drug Saf. 2018 Apr;17(4):437-444. doi: 10.1080/14740338.2018.1442432. Epub 2018 Feb 23. Review.

PMID:
29473429
19.

Mesalazine-induced myocarditis: a case report.

Radhakrishnan ST, Mohanaruban A, Hoque S.

J Med Case Rep. 2018 Feb 22;12(1):44. doi: 10.1186/s13256-017-1557-z.

20.

Systemic allergic dermatitis caused by sodium metabisulfite in rectal enemas.

Borges AS, Valejo Coelho MM, Fernandes C, Brasileiro A, Gonçalo M.

Contact Dermatitis. 2018 Jun;78(6):429-430. doi: 10.1111/cod.12971. Epub 2018 Feb 15. No abstract available.

PMID:
29446100

Supplemental Content

Loading ...
Support Center